Axios @axios
JUST IN: Pfizer says its vaccine was 91.3% effective at protecting against symptomatic COVID up to six months after the second dose, with no serious safety concerns, according to an updated analysis of clinical trial results. https://t.co/A1G528wAQG — PolitiTweet.org